|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2008-3-12
|
|
pubmed:abstractText |
We identified clinical isolates with phenotypic resistance to nevirapine (NVP) in the absence of known nonnucleoside reverse transcriptase inhibitor (NNRTI) mutations. This resistance is caused by N348I, a mutation at the connection subdomain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT). Virologic analysis showed that N348I conferred multiclass resistance to NNRTIs (NVP and delavirdine) and to nucleoside reverse transcriptase inhibitors (zidovudine [AZT] and didanosine [ddI]). N348I impaired HIV-1 replication in a cell-type-dependent manner. Acquisition of N348I was frequently observed in AZT- and/or ddI-containing therapy (12.5%; n = 48; P < 0.0001) and was accompanied with thymidine analogue-associated mutations, e.g., T215Y (n = 5/6) and the lamivudine resistance mutation M184V (n = 1/6) in a Japanese cohort. Molecular modeling analysis shows that residue 348 is proximal to the NNRTI-binding pocket and to a flexible hinge region at the base of the p66 thumb that may be affected by the N348I mutation. Our results further highlight the role of connection subdomain residues in drug resistance.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-10076507,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-10207547,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-11017792,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-11044070,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-11158746,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-11250910,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-11302824,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-12050397,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-12186898,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-12201905,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-12386343,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-12478089,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-12660544,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-12824799,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-15107837,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-15280484,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-15351209,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-15561833,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-15613304,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-15684061,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-15995959,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-16127074,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-16905788,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-17056061,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-17088490,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-17179211,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-17197813,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-17428874,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-17507476,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-18052601,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-2567177,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-7534421,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-7540935,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-7542804,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-7745720,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-8878611,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-9573280,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-9607827,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-9819361,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-9831551,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18216099-9852086
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1098-5514
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3261-70
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18216099-Amino Acid Substitution,
pubmed-meshheading:18216099-Animals,
pubmed-meshheading:18216099-Cell Line,
pubmed-meshheading:18216099-Drug Resistance, Viral,
pubmed-meshheading:18216099-HIV Infections,
pubmed-meshheading:18216099-HIV Reverse Transcriptase,
pubmed-meshheading:18216099-HIV-1,
pubmed-meshheading:18216099-Humans,
pubmed-meshheading:18216099-Microbial Sensitivity Tests,
pubmed-meshheading:18216099-Models, Molecular,
pubmed-meshheading:18216099-Nevirapine,
pubmed-meshheading:18216099-Reverse Transcriptase Inhibitors,
pubmed-meshheading:18216099-Sequence Analysis, DNA,
pubmed-meshheading:18216099-Virus Replication
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors.
|
|
pubmed:affiliation |
Laboratory of Virus Immunology, Research Center for AIDS, Institute for Virus Research, Kyoto University, 53, Kawaramachi, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
